Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 13Lymphoma, Large B-Cell, Diffuse 12Burkitt Lymphoma 12Lymphoma, Follicular 9Lymphoma 7Lymphoma, Non-Hodgkin 6Neoplasms 5Prostatic Neoplasms, Castration-Resistant 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell 4Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Triple Negative Breast Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Melanoma 1Macular dystrophy, corneal type 1 1Lymphoma, Mantle-Cell 1Lymphadenopathy 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3Nivolumab 2Ipilimumab 2CTLA-4 Antigen 2Biopsy 2prednylidene 1deltacortene 1daromun 1cemiplimab 1X-Rays 1Therapeutics 1Sunscreening Agents 1Sirolimus 1Prednisone 1Niacinamide 1Immunoglobulin G 1HhAntag691 1Disulfides 1Blood Specimen Collection 1Antineoplastic Protocols 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × Prednisone × 30 days × Clear all
NCT05896839 2026-06-15

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

National Cancer Institute (NCI)

Phase 1/2 Recruiting
16 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡